DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
FRA:DRW8 - Deutsche Boerse Ag - DE0005550602 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to DRW8. DRW8 was compared to 56 industry peers in the Health Care Equipment & Supplies industry. DRW8 has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on DRW8. With these ratings, DRW8 could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
DRW8 had positive earnings in the past year.
In the past year DRW8 had a positive cash flow from operations.
Of the past 5 years DRW8 4 years were profitable.
Of the past 5 years DRW8 4 years had a positive operating cash flow.
1.2 Ratios
DRW8 has a Return On Assets of 3.75%. This is in the better half of the industry: DRW8 outperforms 64.29% of its industry peers.
DRW8's Return On Equity of 7.54% is fine compared to the rest of the industry. DRW8 outperforms 64.29% of its industry peers.
The Return On Invested Capital of DRW8 (7.13%) is better than 67.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 7.54% | ||
| ROIC | 7.13% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8 has a Profit Margin of 3.42%. This is comparable to the rest of the industry: DRW8 outperforms 50.00% of its industry peers.
DRW8's Profit Margin has improved in the last couple of years.
The Operating Margin of DRW8 (5.77%) is comparable to the rest of the industry.
DRW8's Operating Margin has improved in the last couple of years.
The Gross Margin of DRW8 (44.97%) is worse than 60.71% of its industry peers.
In the last couple of years the Gross Margin of DRW8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.77% | ||
| PM (TTM) | 3.42% | ||
| GM | 44.97% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DRW8 is still creating some value.
Compared to 1 year ago, DRW8 has less shares outstanding
The number of shares outstanding for DRW8 has been increased compared to 5 years ago.
DRW8 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.61 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.61, DRW8 is in line with its industry, outperforming 53.57% of the companies in the same industry.
The Debt to FCF ratio of DRW8 is 2.08, which is a good value as it means it would take DRW8, 2.08 years of fcf income to pay off all of its debts.
DRW8's Debt to FCF ratio of 2.08 is amongst the best of the industry. DRW8 outperforms 82.14% of its industry peers.
DRW8 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DRW8 (0.10) is better than 82.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.08 | ||
| Altman-Z | 2.61 |
ROIC/WACC1.14
WACC6.26%
2.3 Liquidity
A Current Ratio of 1.81 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Current ratio (1.81) which is comparable to the rest of the industry.
DRW8 has a Quick Ratio of 1.12. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
DRW8 has a Quick ratio of 1.12. This is comparable to the rest of the industry: DRW8 outperforms 48.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.79% over the past year.
Measured over the past years, DRW8 shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.42% on average per year.
The Revenue has been growing slightly by 0.51% in the past year.
DRW8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.92% yearly.
EPS 1Y (TTM)14.79%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-129.48%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.76%
3.2 Future
DRW8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.55% yearly.
The Revenue is expected to grow by 2.64% on average over the next years.
EPS Next Y0.82%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
EPS Next 5Y6.55%
Revenue Next Year3.83%
Revenue Next 2Y3.96%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.66 indicates a reasonable valuation of DRW8.
DRW8's Price/Earnings ratio is rather cheap when compared to the industry. DRW8 is cheaper than 98.21% of the companies in the same industry.
DRW8's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.25.
Based on the Price/Forward Earnings ratio of 8.54, the valuation of DRW8 can be described as reasonable.
94.64% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.80, DRW8 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.66 | ||
| Fwd PE | 8.54 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 92.86% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DRW8 is valued cheaply inside the industry as 96.43% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.62 | ||
| EV/EBITDA | 3.08 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DRW8 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)11.78
PEG (5Y)0.27
EPS Next 2Y8.16%
EPS Next 3Y10.79%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.44%, DRW8 has a reasonable but not impressive dividend return.
DRW8's Dividend Yield is rather good when compared to the industry average which is at 2.38. DRW8 pays more dividend than 92.86% of the companies in the same industry.
DRW8's Dividend Yield is a higher than the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.44% |
5.2 History
The dividend of DRW8 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
28.77% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
The dividend of DRW8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.77%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
FRA:DRW8 (7/31/2025, 7:00:00 PM)
59.4
-0.2 (-0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners9.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.11B
Analysts74.67
Price Target72.65 (22.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.44% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP28.77%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.66 | ||
| Fwd PE | 8.54 | ||
| P/S | 0.33 | ||
| P/FCF | 8.62 | ||
| P/OCF | 5.87 | ||
| P/B | 0.73 | ||
| P/tB | 0.94 | ||
| EV/EBITDA | 3.08 |
EPS(TTM)6.15
EY10.35%
EPS(NY)6.95
Fwd EY11.71%
FCF(TTM)6.89
FCFY11.6%
OCF(TTM)10.11
OCFY17.02%
SpS179.39
BVpS81.51
TBVpS63.3
PEG (NY)11.78
PEG (5Y)0.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.75% | ||
| ROE | 7.54% | ||
| ROCE | 9.48% | ||
| ROIC | 7.13% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 10.31% | ||
| OM | 5.77% | ||
| PM (TTM) | 3.42% | ||
| GM | 44.97% | ||
| FCFM | 3.84% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-18.01%
ROICexcg growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.08 | ||
| Debt/EBITDA | 0.45 | ||
| Cap/Depr | 41.06% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 10.18 | ||
| Cash Conversion | 55.59% | ||
| Profit Quality | 112.21% | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 2.61 |
F-Score6
WACC6.26%
ROIC/WACC1.14
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.79%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-129.48%
EPS Next Y0.82%
EPS Next 2Y8.16%
EPS Next 3Y10.79%
EPS Next 5Y6.55%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.76%
Revenue Next Year3.83%
Revenue Next 2Y3.96%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%
EBIT growth 1Y16.32%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.53%
EBIT Next 3Y29.41%
EBIT Next 5Y12.44%
FCF growth 1Y165.3%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y253.6%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%